Structural heart disease refers to defects in the heart that you are born with, but may also include abnormalities of the valves and vessels of the heart wall that develop due to aging, injury or infection.
The OhioHealth Structural Heart Disease Program provides comprehensive evaluation, diagnosis and treatment for patients with structural heart conditions. We specialize in treating patients with advanced and complex structural heart disease, who may not qualify for conventional surgery.
Each patient at the OhioHealth Structural Heart Disease Clinics receives personalized care by an entire team of experts – all in a single visit. The multidisciplinary team of cardiothoracic surgeons, cardiologists, nurses and other clinicians who specialize in structural heart conditions work together to determine the best course of treatment for you, which may include participation in clinical trials testing leading-edge therapies.
Learn more about our program and meet some of our physicians.
On the forefront of revolutionizing care for structural heart disease
Our Structural Heart Disease team is a national leader in the use of minimally invasive procedures that are revolutionizing the treatment of heart valve disease. We have been involved in numerous clinical trials that have led to the FDA-approval of new devices to treat heart valve disease, giving a life-saving treatment option for high-risk patients.
Our research has also been published in the New England Journal of Medicine and the Journal of the American College of Cardiology and we have been recognized as one of the top structural heart disease programs in the country.
Learn more about why we participate in clinical trials.
An Alternative to Major Surgery
Many patients with structural heart conditions such as severe aortic stenosis and mitral regurgitation are too ill or too frail for open-heart surgery, the standard treatment for these conditions. Thanks to the groundbreaking clinical research at OhioHealth, many of these patients now have an alternative treatment option.
For patients with aortic stenosis, a bioprosthetic valve is implanted through a catheter that is inserted through the groin, shoulder or directly between the ribs, depending on the patient’s condition and anatomy. Called transcatheter aortic valve replacement or TAVR, this is a minimally invasive procedure and patients go home within two to three days.
Physicians at OhioHealth were among the first in the nation to perform TAVR procedures and have some of the best outcomes because of their extensive experience.
Read why 88-year-old Eileen felt like doing somersaults after her TAVR procedure.
Patients with mitral regurgitation may qualify for transcatheter mitral valve repair (TMVR). During the minimally invasive procedure, the leaky flaps of the mitral valve are clipped together using the MitraClip device and patients go home the next day.
Watch Bob’s story and hear how transcatheter mitral valve repair has gotten him off the sidelines and back in the fairway.
Conditions we treat
Advanced procedures and services include:
- Catheter-based replacement of an aortic valve (TAVR)
- Catheter-based repair of a mitral valve using the MitraClip® device
- Catheter-based left atrial appendage (LAA) closure for stroke prevention in atrial fibrillation patients using the WATCHMAN™ or LARIAT™ devices
- Percutaneous aortic and mitral valvuloplasty to insert a balloon that expands narrow heart valves
- Catheter-based closure of patent foramen ovale (PFO) and atrial septal defects (ASD)
- Catheter-based closure of valve leaks in patients considered high risk for surgery
- Catheter-based treatment to help restore heart muscle function post heart attack in heart failure patients using the PARACHUTE™ device
OhioHealth Care Locations for This Program